03.02.2025 • NewsTakedaPeople

Julie Kim to Succeed Christophe Weber as CEO of Takeda

Takeda has appointed Julie Kim, currently president of the company’s US business unit, to succeed Christophe Weber as CEO in June 2026, who will retire after 12 years in this role.

Kim joined Takeda in 2019 through the acquisition of Shire, where she held several roles with increasing responsibility. She became the president of the Plasma-Derived Therapies business unit and held this position until April 2022, when she became president of the US business unit and US country head.

With three decades working in health care and leadership positions at global, regional, country and functional levels, her experiences cover a variety of therapeutic areas, international market access, country and regional general management, marketing and emerging market development.

Kim earned an MBA from the J. L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree in economics from Dartmouth College.

Julie Kim to Succeed Christophe Weber as CEO of Takeda

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.